tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market

Royalty Pharma (RPRX) Technical Analysis

Compare
1,248 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Royalty Pharma PLC’s (RPRX) Moving Averages Convergence Divergence (MACD) indicator is 1.09, suggesting Royalty Pharma PLC is a Buy.
Royalty Pharma PLC’s (RPRX) 20-Day exponential moving average is 31.63, while Royalty Pharma PLC’s (RPRX) share price is $33.42, making it a Buy.
Royalty Pharma PLC’s (RPRX) 50-Day exponential moving average is 29.78, while Royalty Pharma PLC’s (RPRX) share price is $33.42, making it a Buy.

Royalty Pharma (RPRX) Pivot Points

Feb 23, 2025, 04:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
30.95
31.62
32.36
33.03
33.77
34.44
35.18
Fibonacci
31.62
32.16
32.49
33.03
33.57
33.90
34.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Royalty Pharma (RPRX) Moving Averages

Feb 23, 2025, 04:00 AM
Period
Simple
Exponential
MA5
32.74Buy
32.84Buy
MA10
32.31Buy
32.40Buy
MA20
31.81Buy
31.63Buy
MA50
28.73Buy
29.78Buy
MA100
27.70Buy
28.57Buy
MA200
27.32Buy
28.00Buy
Royalty Pharma PLC’s (RPRX) 10-Day exponential moving average is 32.40, while Royalty Pharma PLC’s (RPRX) share price is $33.42, making it a Buy.
Royalty Pharma PLC’s (RPRX) 100-Day exponential moving average is 28.57, while Royalty Pharma PLC’s (RPRX) share price is $33.42, making it a Buy.
Royalty Pharma PLC’s (RPRX) stock price is $33.42 and Royalty Pharma PLC’s (RPRX) 50-day simple moving average is 28.73, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $33.42 and Royalty Pharma PLC’s (RPRX) 100-day simple moving average is 27.70, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $33.42 and Royalty Pharma PLC’s (RPRX) 200-day simple moving average is 27.32, creating a Buy signal.

Royalty Pharma (RPRX) Technical Indicators

Feb 23, 2025, 04:00 AM
Name
Value
Implied Action
RSI (14)
79.36
Sell
STOCH (9,6)
77.36
Neutral
STOCHRSI (14)
79.71
Neutral
MACD (12,26)
1.09
Buy
ADX (14)
50.68
Sell
Williams %R
-10.15
Sell
CCI (14)
188.46
Sell
ATR (14)
0.74
-
Ultimate Oscillator
40.28
Neutral
ROC
6.53
Buy
Royalty Pharma PLC’s (RPRX) Relative Strength Index (RSI) is 79.36, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) Trend Strength Indicator (ADX) is 50.68, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) Commodity Channel Index (CCI) is 188.46, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) Price Rate of Change (ROC) is 6.53, creating a Buy signal.

FAQ

Is RPRX a Buy, Hold, or Sell?
Based on RPRX’s technical indicators, RPRX is a Buy.
    What is RPRX’s RSI (14)?
    RPRX’s RSI (14) is 79.36, which suggests RPRX is a Sell.
      What is RPRX’s MACD?
      RPRX’s MACD is 1.09, which suggests RPRX is a Buy.
        What is RPRX’s 5-day moving average?
        RPRX’s 5-day moving average is 32.74, which suggests RPRX is a Buy.
          What is RPRX’s 20-day moving average?
          RPRX 20-day moving average is 31.81, which suggests RPRX is a Buy.
            What is RPRX’s 50-day moving average?
            RPRX’s 50-day moving average is 28.73, which suggests RPRX is a Buy.
              What is RPRX’s 200-day moving average?
              RPRX’s 200-day moving average is 27.32, which suggests RPRX is a Buy.
                What is RPRX’s Williams % R (14)?
                RPRX’s Williams % R (14) is -10.15, which suggests RPRX is a Sell.
                  What is RPRX’s CCI (14)?
                  RPRX’s CCI (14) is 188.46, which suggests RPRX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis